Celiac disease in a child with beta-thalassemia major: a need for improved screening and awareness

Ankit Parakh1, Sreedharan Sudha, Anand Prakash Dubey

  • 1Thalassemia Unit, Division of Pediatric Hematology-Oncology, Department of Paediatrics, Maulana Azad Medical College, New Delhi, India. ankitparakh102@rediffmail.com

Insights

Celiac disease is an underdiagnosed cause of growth failure in children with beta-thalassemia major. A gluten-free diet rapidly improved weight and height velocity in a 10-year-old boy.

Area of Science:

  • Pediatrics
  • Genetics and Heredity
  • Gastroenterology

Background:

  • Growth failure is a common complication in children with thalassemia major, often stemming from multiple factors.
  • Identifying all causes of growth failure is crucial for effective management in these patients.

Observation:

  • A 10-year-old boy with beta-thalassemia major presented with early-onset growth failure despite a hypertransfusion regimen.
  • Initial investigations ruled out common causes like viral infections, zinc deficiency, and growth hormone deficiency.
  • Despite the absence of gastrointestinal symptoms, malabsorption was suspected due to persistent growth failure.

Findings:

  • Elevated tissue transglutaminase levels (>300 IU/mL) strongly indicated celiac disease.
  • Jejunal biopsy revealed characteristic mucosal lesions, confirming the diagnosis of celiac disease.
  • The patient had beta-thalassemia major, a genetic blood disorder.

Implications:

  • Celiac disease should be considered as an underdiagnosed cause of growth failure in children with beta-thalassemia major.
  • Prompt diagnosis and institution of a gluten-free diet can lead to significant improvements in growth parameters.
  • This case highlights the importance of a comprehensive diagnostic approach for growth failure in pediatric patients with chronic conditions.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...